These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8561961)

  • 21. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
    Johnson BN; Yamamoto BK
    J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restraint as a stressor in mice: against the dopaminergic neurotoxicity of D-MDMA, low body weight mitigates restraint-induced hypothermia and consequent neuroprotection.
    Johnson EA; Sharp DS; Miller DB
    Brain Res; 2000 Sep; 875(1-2):107-18. PubMed ID: 10967304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine.
    Callahan BT; Cord BJ; Ricaurte GA
    Synapse; 2001 May; 40(2):113-21. PubMed ID: 11252022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
    Fantegrossi WE; Godlewski T; Karabenick RL; Stephens JM; Ullrich T; Rice KC; Woods JH
    Psychopharmacology (Berl); 2003 Mar; 166(3):202-11. PubMed ID: 12563544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response.
    Broening HW; Bowyer JF; Slikker W
    J Pharmacol Exp Ther; 1995 Oct; 275(1):325-33. PubMed ID: 7562567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
    Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
    Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY; Albers DS; Sonsalla PK
    Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone.
    Johnson BN; Yamamoto BK
    Neuroscience; 2009 Apr; 159(4):1233-43. PubMed ID: 19409219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain.
    Frau L; Simola N; Porceddu PF; Morelli M
    Neurotoxicology; 2016 Sep; 56():127-138. PubMed ID: 27451954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
    Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice.
    Barros-Miñones L; Goñi-Allo B; Suquia V; Beitia G; Aguirre N; Puerta E
    Neuropharmacology; 2015 Jun; 93():124-33. PubMed ID: 25666033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
    Rodsiri R; Green AR; Marsden CA; Fone KC
    J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
    O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
    Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.
    Farfel GM; Seiden LS
    J Pharmacol Exp Ther; 1995 Feb; 272(2):860-7. PubMed ID: 7531765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
    Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
    Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles.
    Malberg JE; Seiden LS
    Brain Res; 1997 Aug; 765(1):101-7. PubMed ID: 9310399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
    Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
    J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA.
    Falk EM; Cook VJ; Nichols DE; Sprague JE
    Pharmacol Biochem Behav; 2002 Jun; 72(3):617-22. PubMed ID: 12175458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.